| John Mason Erwin, CRNA | |
|
1006 Tavern Rd, Martinsburg, WV 25401-2864 | |
| (304) 267-0556 | |
| (304) 267-1460 |
| Full Name | John Mason Erwin |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 12 Years |
| Location | 1006 Tavern Rd, Martinsburg, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386980969 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R181627 (Maryland) | Primary |
| 163W00000X | Registered Nurse | R181627 (Maryland) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Meritus Medical Center | Hagerstown, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| First Colonies Anesthesia Associates, Llc | 8426039744 | 359 |
| First Colonies Anesthesia Associates, Llc | 8426039744 | 359 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
New classes of therapeutic antisense oligonucleotides can have toxic effects on the liver. A novel machine learning-based approach used to predict the hepatotoxic potential of an antisense drug based on its chemical sequence is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
Elite Pharmaceuticals, Inc. announced today the signing of a license agreement and a manufacturing and supply agreement with Precision Dose, Inc. which has a wholly owned subsidiary, TAGI Pharma, Inc. which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products in the United States, Puerto Rico and Canada.
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that, on June 1, 2010, the Company received a letter from The Nasdaq Stock Market indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, Nile was not in compliance with Marketplace Rule 5550(a)(2).
"In her first visit to Geneva as Russian G20 Sherpa, Ksenia Yudaeva" - Chief of the Presidential Experts Directorate - "visited UNAIDS Headquarters for a broad-ranging discussion on global issues that are priorities for the Russian Presidency of the G20, including civil society participation, youth empowerment and development for all," UNAIDS reports in an article on its webpage.
› Verified 5 days ago
| Entity Name | First Colonies Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740218767 PECOS PAC ID: 8426039744 Enrollment ID: O20040525000119 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
New classes of therapeutic antisense oligonucleotides can have toxic effects on the liver. A novel machine learning-based approach used to predict the hepatotoxic potential of an antisense drug based on its chemical sequence is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
Elite Pharmaceuticals, Inc. announced today the signing of a license agreement and a manufacturing and supply agreement with Precision Dose, Inc. which has a wholly owned subsidiary, TAGI Pharma, Inc. which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products in the United States, Puerto Rico and Canada.
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that, on June 1, 2010, the Company received a letter from The Nasdaq Stock Market indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, Nile was not in compliance with Marketplace Rule 5550(a)(2).
"In her first visit to Geneva as Russian G20 Sherpa, Ksenia Yudaeva" - Chief of the Presidential Experts Directorate - "visited UNAIDS Headquarters for a broad-ranging discussion on global issues that are priorities for the Russian Presidency of the G20, including civil society participation, youth empowerment and development for all," UNAIDS reports in an article on its webpage.
› Verified 5 days ago
| Entity Name | Anesthesia Management Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467880500 PECOS PAC ID: 8729217955 Enrollment ID: O20140210000652 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
New classes of therapeutic antisense oligonucleotides can have toxic effects on the liver. A novel machine learning-based approach used to predict the hepatotoxic potential of an antisense drug based on its chemical sequence is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
Elite Pharmaceuticals, Inc. announced today the signing of a license agreement and a manufacturing and supply agreement with Precision Dose, Inc. which has a wholly owned subsidiary, TAGI Pharma, Inc. which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products in the United States, Puerto Rico and Canada.
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that, on June 1, 2010, the Company received a letter from The Nasdaq Stock Market indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, Nile was not in compliance with Marketplace Rule 5550(a)(2).
"In her first visit to Geneva as Russian G20 Sherpa, Ksenia Yudaeva" - Chief of the Presidential Experts Directorate - "visited UNAIDS Headquarters for a broad-ranging discussion on global issues that are priorities for the Russian Presidency of the G20, including civil society participation, youth empowerment and development for all," UNAIDS reports in an article on its webpage.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Mason Erwin, CRNA 220 Campus Blvd Ste 210, Winchester, VA 22601-2889 Ph: (540) 536-5100 | John Mason Erwin, CRNA 1006 Tavern Rd, Martinsburg, WV 25401-2864 Ph: (304) 267-0556 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
New classes of therapeutic antisense oligonucleotides can have toxic effects on the liver. A novel machine learning-based approach used to predict the hepatotoxic potential of an antisense drug based on its chemical sequence is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
Elite Pharmaceuticals, Inc. announced today the signing of a license agreement and a manufacturing and supply agreement with Precision Dose, Inc. which has a wholly owned subsidiary, TAGI Pharma, Inc. which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products in the United States, Puerto Rico and Canada.
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that, on June 1, 2010, the Company received a letter from The Nasdaq Stock Market indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, Nile was not in compliance with Marketplace Rule 5550(a)(2).
"In her first visit to Geneva as Russian G20 Sherpa, Ksenia Yudaeva" - Chief of the Presidential Experts Directorate - "visited UNAIDS Headquarters for a broad-ranging discussion on global issues that are priorities for the Russian Presidency of the G20, including civil society participation, youth empowerment and development for all," UNAIDS reports in an article on its webpage.
› Verified 5 days ago
Mercedes L Dockeney, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1006 Tavern Rd, Martinsburg, WV 25401 Phone: 304-267-0556 Fax: 304-267-1460 | |
Cerissa C. Wehrle, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2500 Hospital Dr, Martinsburg, WV 25401 Phone: 304-264-1000 | |
Ms. Lindsey Paige Evers, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1006 Tavern Rd, Martinsburg, WV 25401 Phone: 304-267-0556 Fax: 304-267-1460 | |
Donovan Bregg, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2500 Hospital Dr, Martinsburg, WV 25401 Phone: 304-264-1000 Fax: 304-264-1325 | |
Gregory Alan Cresswell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2500 Hospital Dr, Martinsburg, WV 25401 Phone: 304-264-1000 | |
Thomas H Downey, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1006 Tavern Rd, Martinsburg, WV 25401 Phone: 304-267-5141 Fax: 304-267-5140 |